Oric Pharmaceuticals (ORIC) Depreciation & Amortization (CF) (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Depreciation & Amortization (CF) of $270000.0 for Q1 2026, down 10.0% on a QoQ basis from $300000.0 in Q4 2025, and down 10.6% year-over-year from $302000.0 in Q1 2025.
Oric Pharmaceuticals (ORIC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $270000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 10.6% year-over-year to $270000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2.37% YoY) and the FY2025 annual result came in at $1.2 million, up 9.09% from the prior year.
- Depreciation & Amortization (CF) was $270000.0 for Q1 2026 at Oric Pharmaceuticals, down from $300000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $310000.0 in Q2 2025 and bottomed at $221000.0 in Q3 2022.
- A 5-year average of $270705.9 and a median of $270000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) advanced 21.12% — and 2026, when it declined 10.6%.
- Oric Pharmaceuticals' Depreciation & Amortization (CF) stood at $281000.0 in 2022, then fell by 6.41% to $263000.0 in 2023, then rose by 12.93% to $297000.0 in 2024, then rose by 1.01% to $300000.0 in 2025, then retreated by 10.0% to $270000.0 in 2026.
- Business Quant data shows ORIC's Depreciation & Amortization (CF) at $270000.0 in Q1 2026, $300000.0 in Q4 2025, and $288000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | 270,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270,000.00 |
| Mar 31, 2026 | 270,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 288,000.00 |
| Sep 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 310,000.00 |
| Jun 30, 2025 | 310,000.00 |
| Mar 31, 2025 | 302,000.00 |
| Mar 31, 2025 | 302,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Sep 30, 2024 | 270,000.00 |
| Sep 30, 2024 | 270,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 261,000.00 |
| Mar 31, 2024 | 261,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |